drugset / Trial / NCT05548452

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

NCT05548452 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.

Timeline

Start
2022-11-21
Primary completion
2027-05
Completion
2027-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Intestinal Microbiota Transplant Other / unclassified — —